L Arginine

DIETARY_SUPPLEMENT3 trials

Sponsors

Hospital Civil Juan I. Menchaca, Colgate Palmolive, Faculty of medicine Tanta University

Conditions

Caries,DentalHaematological Disorders PaediatricsPreeclampsia

Phase 1

Maximal Use Study to Determine the Pharmacokinetics of L-arginine After Exaggerated Oral Use of COL101

CompletedNCT06182267

Colgate PalmoliveCaries,Dental

Start: 2023-11-27End: 2023-12-22Updated: 2024-01-02

Phase 2

The Efficacy of Oral L-Arginine Therapy for The Treatment of Vaso-Occlusive Pain Episodes in Children with Sickle Cell Disease

Active, not recruitingPACTR202507722471802

Faculty of medicine Tanta UniversityHaematological Disorders Paediatrics

Start: 2022-08-10Target: 40Updated: 2026-01-27

Phase 3

Efficacy and Safety of L Arginine to Prevent Preeclampsia

CompletedNCT02363348

Hospital Civil Juan I. MenchacaPreeclampsia

Start: 2010-08-31End: 2014-03-31Updated: 2016-03-04